Annual ROA
-61.11%
+2.93%+4.58%
31 December 2023
Summary:
Revance Therapeutics annual return on assets is currently -61.11%, with the most recent change of +2.93% (+4.58%) on 31 December 2023. During the last 3 years, it has fallen by -16.15% (-35.92%). RVNC annual ROA is now -94.74% below its all-time high of -31.38%, reached on 31 December 2015.RVNC ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-37.25%
+17.80%+32.33%
30 September 2024
Summary:
Revance Therapeutics quarterly return on assets is currently -37.25%, with the most recent change of +17.80% (+32.33%) on 30 September 2024. Over the past year, it has increased by +21.90% (+37.02%). RVNC quarterly ROA is now -19.85% below its all-time high of -31.08%, reached on 30 June 2015.RVNC Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +37.0% |
| 3 y3 years | -35.9% | +16.6% |
| 5 y5 years | -8.6% | +32.1% |
RVNC ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -35.9% | +4.6% | at high | +46.6% |
| 5 y | 5 years | -35.9% | +4.6% | at high | +46.6% |
| alltime | all time | -94.7% | +79.0% | -19.9% | +88.7% |
Revance Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -37.25%(-32.3%) |
| June 2024 | - | -55.05%(-7.5%) |
| Mar 2024 | - | -59.54%(+0.7%) |
| Dec 2023 | -61.11%(-4.6%) | -59.15%(-15.1%) |
| Sept 2023 | - | -69.70%(+16.9%) |
| June 2023 | - | -59.60%(+3.0%) |
| Mar 2023 | - | -57.88%(-1.8%) |
| Dec 2022 | -64.04%(+42.4%) | -58.95%(+30.2%) |
| Sept 2022 | - | -45.26%(+1.5%) |
| June 2022 | - | -44.59%(-0.1%) |
| Mar 2022 | - | -44.64%(-0.0%) |
| Dec 2021 | -44.96%(-15.5%) | -44.65%(+0.3%) |
| Sept 2021 | - | -44.51%(-2.4%) |
| June 2021 | - | -45.62%(+2.5%) |
| Mar 2021 | - | -44.52%(-7.2%) |
| Dec 2020 | -53.20%(-5.5%) | -47.95%(-4.2%) |
| Sept 2020 | - | -50.07%(-0.9%) |
| June 2020 | - | -50.52%(-1.2%) |
| Mar 2020 | - | -51.13%(-6.8%) |
| Dec 2019 | -56.27%(+3.0%) | -54.87%(-4.6%) |
| Sept 2019 | - | -57.49%(+5.3%) |
| June 2019 | - | -54.58%(+1.5%) |
| Mar 2019 | - | -53.79%(-2.0%) |
| Dec 2018 | -54.62% | -54.88%(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -55.51%(-2.2%) |
| June 2018 | - | -56.73%(+1.2%) |
| Mar 2018 | - | -56.04%(-0.9%) |
| Dec 2017 | -48.23%(+29.7%) | -56.57%(+1.2%) |
| Sept 2017 | - | -55.91%(+20.5%) |
| June 2017 | - | -46.40%(+9.3%) |
| Mar 2017 | - | -42.46%(+14.4%) |
| Dec 2016 | -37.18%(+18.5%) | -37.10%(+2.1%) |
| Sept 2016 | - | -36.32%(-6.1%) |
| June 2016 | - | -38.68%(+3.9%) |
| Mar 2016 | - | -37.22%(-0.6%) |
| Dec 2015 | -31.38%(-46.4%) | -37.46%(+4.4%) |
| Sept 2015 | - | -35.89%(+15.5%) |
| June 2015 | - | -31.08%(-0.9%) |
| Mar 2015 | - | -31.35%(-24.8%) |
| Dec 2014 | -58.50%(-79.9%) | -41.71%(-17.6%) |
| Sept 2014 | - | -50.61%(-12.4%) |
| June 2014 | - | -57.76%(-45.3%) |
| Mar 2014 | - | -105.51%(-63.1%) |
| Dec 2013 | -290.83%(+33.2%) | -286.14%(-13.1%) |
| Sept 2013 | - | -329.41%(-0.4%) |
| June 2013 | - | -330.68%(+36.3%) |
| Mar 2013 | - | -242.55%(+198.7%) |
| Dec 2012 | -218.40%(+94.4%) | -81.21% |
| Dec 2011 | -112.36% | - |
FAQ
- What is Revance Therapeutics annual return on assets?
- What is the all time high annual ROA for Revance Therapeutics?
- What is Revance Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Revance Therapeutics?
- What is Revance Therapeutics quarterly ROA year-on-year change?
What is Revance Therapeutics annual return on assets?
The current annual ROA of RVNC is -61.11%
What is the all time high annual ROA for Revance Therapeutics?
Revance Therapeutics all-time high annual return on assets is -31.38%
What is Revance Therapeutics quarterly return on assets?
The current quarterly ROA of RVNC is -37.25%
What is the all time high quarterly ROA for Revance Therapeutics?
Revance Therapeutics all-time high quarterly return on assets is -31.08%
What is Revance Therapeutics quarterly ROA year-on-year change?
Over the past year, RVNC quarterly return on assets has changed by +21.90% (+37.02%)